课题基金 / 基金详情

Consortium for Enhancing Human Subject Research Oversite

Consortium for Enhancing Human Subject Research Oversite
加强人类受试者现场研究联盟
批准号:
6591619
负责人:
LEONARD H ROME
金额:
$50.0万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-09-01 至 2003-09-14

项目摘要

项目成果

LEONARD H ROME的其他基金

相关文献

中文摘要
翻译
加州大学洛杉矶分校,兰德公司和查尔斯R。德鲁医学与科学大学有一个长期的 历史性的合作,包括联合教师任命,研究合作和 交换行政服务。我们的三个机构正在加入一个伙伴关系, 联合收割机将重要的机构资源与这里要求的资金结合起来,生产软件, 数据库和教育增强系统,将用于所有三个机构, 加强人体研究、监督、教育和培训。加州大学洛杉矶分校,兰德, Charles R.德鲁大学医学与科学联盟将:创造一个智能的 机构审查委员会(IRB)电子提交和跟踪系统,用于审查, 批准和监测人类受试者的研究;扩大和加强我们目前的人类 主题研究网上认证和培训计划;以及加强内部支持 以及对大学临床试验的监督。
英文摘要
UCLA, RAND, and the Charles R. Drew University of Medicine & Science have a long-standing historical collaboration that includes joint faculty appointments, research collaborations and the exchange of administrative services. Our three institutions are joining into a partnership in order to combine significant institutional resources with funds requested here to produce software, databases and educational enhancement systems that will be used by all three institutions to enhance human subject research, oversight, education and training. The UCLA, RAND, and Charles R. Drew University of Medicine & Science consortium will: create an intelligent Institutional Review Board (IRB) electronic submission and tracking system for the review, approval, and monitoring of human subjects research; expand and enhance our current human subject research web based certification and training program; and, enhance internal support and monitoring of University based clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vault-CCL21 Nanocapsule for Lung Cancer
  • 批准号:
    9321253
  • 项目类别:
  • 资助金额:
    $16.88万
  • 财政年份:
    2012
  • 负责人:
    LEONARD H ROME
  • 依托单位:
Vault-CCL21 Nanocapsule for Lung Cancer
  • 批准号:
    8698250
  • 项目类别:
  • 资助金额:
    $66.92万
  • 财政年份:
    2012
  • 负责人:
    LEONARD H ROME
  • 依托单位:
Vaults as Nonviral Nucleic Acid Delivery Vehicles
Vaults as Nonviral Nucleic Acid Delivery Vehicles